Pneumonia outbreak associated with group A Streptococcus species at a military training facility

Clinical Infectious Diseases

Volumn 40, Issue 4, 2005, Pages 511-518

  Crum, Nancy F ^a   Russell, Kevin L ^a   Kaplan, Edward L ^c   Wallace, Mark R ^a   Wu, Jianguo ^a   Ashtari, Parvin ^a   Morris, Dana J ^b   Hale, Brader R ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Marine Corps Recruit Depot   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SAILOR; SOLDIER; SPECIES DIFFERENTIATION; STREPTOCOCCUS GROUP A; TRAINING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; HUMANS; MILITARY PERSONNEL; PENICILLINS; PHARYNX; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES;

EID: 13944251339     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427502     Document Type: Article

References (55)

1. Thomas RJ, Conwill DE, Morton DE, Brooks TJ, Holmes CK, Mahaffey WB. Penicillin prophylaxis for streptococcal infections in the United States Navy and Marine Corps recruit camps, 1951-1985. Rev Infect Dis 1988; 10:125-30.
2. History and accomplishments: an introduction to NAMRU-4. Great Lakes, IL: Naval Medical Research Unit No. 4, 1972.
3. Davison WC. Reduction of communicable diseases among troops and children during national defense program. War Medicine 1941; 1: 863-72.
4. Acute rheumatic fever among army trainees-Fort Leonard Wood, Missouri, 1987-1988. MMWR Morb Mortal Wkly Rep 1988; 37: 519-22.
5. Wallace MR, Garst PD, Papadimos TJ, Oldfield EC 3rd. The return of acute rheumatic fever in young adults. JAMA 1989; 262:2557-61.
6. Gunzenhauser JD, Longfield JN, Brundage JF, Kaplan EL, Miller RN, Brandt CA. Epidemic streptococcal disease among Army trainees, July 1989 through June 1991. J Infect Dis 1995; 172:124-31.
7. Dully FE Jr. Streptococcal epidemic in an aircraft carrier. Aerosp Med 1973; 44:1181-2.
8. Bloomfield AL, Rantz LA. An outbreak of streptococcal septic sore throat in an army camp. JAMA 1943; 121:315-9.
9. Welch CC, Tombridge TL, Baker WJ, Kinney RJ. Betahemolytic streptococcal pneumonia: report of an outbreak in a military population. Am J Med Sc 1961; 242:157-65.
10. Basiliere JL, Bistrong HW, Spence WF. Streptococcal pneumonia: recent outbreaks in military recruit population. Am J Med 1968; 44:580-9.
11. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 1951; 10:673-95.
12. Rammelkamp CH Jr. Armed Forces Epidemiological Board. Activities of the Commission on Streptococcal and Staphylococcal Diseases. Mil Med 1962; 127:1007-8.
13. Stevens DL, Kaplan EL. Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford Press, 2000.
14. Greenberg JH. Streptococcal disease in the United States Army. Am J Public Health 1962; 52:223-34.
15. McFarland RB, Colvin VG, Seal JR. Mass prophylaxis of epidemic streptococcal infections with benzathine penicillin G. II. Experience at a naval training center during the winter of 1956-57. N Engl J Med 1958; 258:1277-84.
16. Schreier AJ, Hockett VE, Seal JR. Mass prophylaxis of epidemic streptococcal infections with benzathine penicillin G. I. Experience at a naval training center during the winter of 1955-56. N Engl J Med 1958; 258:1231-8.
17. Seal JR. Mass prophylaxis of epidemic streptococcal infections; report on the use of penicillin prophylaxis in the Navy during the winter of 1954 to 1955. Antibiot Annu 1955-1956; 3:202-16.
18. Miller LF. Prophylactic procedures in Navy recruits. Mil Med 1963; 128:858-66.
19. Frank PF, Stollerman GH, Miller LF. Protection of a military population from rheumatic fever. Routine administration of benzathine penicillin G to healthy individuals. JAMA 1965; 193:775-83.
20. Frank PF. Streptococcal prophylaxis in Navy recruits with oral and benzathine penicillin. US Armed Forces Med J 1958; 9:543-60.
21. Johnson DR, Sramek J, Kaplan EL, et al. Laboratory diagnosis of group A streptococcal infections: a laboratory manual. World Health Organization Collaborating Center for Reference and Research on Streptococci. Geneva: World Health Organization, 1996.
22. Beall B, Facklam R, Thompson T. Sequencing emm-specifk PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34:953-8.
23. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 2001; 69:2416-27.
24. Black CM, Talkington DF, Messmer TO, Facklam RR, Hornes E, Olsvik O. Detection of streptococcal pyrogenic exotoxin genes by a nested polymerase chain reaction. Mol Cell Probes 1993; 7:255-9.
25. Thacker WL, Talkington DF. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diag Lab Immunol 2000; 7:778-80.
26. Waites KB, Thacker WL. The value of culture and serology for detection of Mycoplasma pneumoniae infections in the clinical laboratory in the age of molecular diagnostics. Clinical Microbiology Newsletter 2001; 23:123-30.
27. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33:492-503.
28. Birch C, Gowardman J. Streptococcus pyogenes: a forgotten cause of severe community-acquired pneumonia. Anaesth Intensive Care 2000; 28:87-90.
29. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1:671-4.
30. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35:268-76.
31. Muller MP, Low DE, Green KA, et al. Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003; 163:467-72.
32. Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC. Respiratory diseases among US military personnel: countering emerging threats. Emerg Infect Dis 1999; 5:379-85.
33. Gray GC, Goswami PR, Malasig MD, et al. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Adenovirus Surveillance Group. Clin Infect Dis 2000; 31: 663-70.
34. Crum NF, Wallace MR, Lamb CR, et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. Am J Prev Med 2003; 25:107-11.
35. Brundage JF, Ryan MA, Feighner BH, Erdtmann FJ. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998. Clin Infect Dis 2002; 35:1376-81.
36. Gerber P, Woolridge RL, Seal JR, Ziegra SR. Epidemic influenza B and C in Navy recruits during winter of 1951-52. Proc Soc Exp Biol Med 1952; 81.
37. Rosenbaum MJ, Edwards EA, Frank PF, Pierce WE, Crawford YE. Epidemiology and prevention of acute respiratory disease in Naval recruits. I. Ten years' experience with microbial agents isolated from Naval recruits with acute respiratory disease. Am J Public Health Nations Health 1965; 55:38-46.
38. Bass JW, Longfield JN, Jones RG, Hartman RM. Serum levels of penicillin in basic trainees in the US Army who received intramuscular penicillin G benzathine. Clin Infect Dis 1996; 22:727-8.
39. Gray GC, McPhate DC, Leinonen M, et al. Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis 1998;26:103-10.
40. Gunzenhauser JD, Brundage JF, McNeil JG, Miller RN. Broad and persistent effects of benzathine penicillin G in the prevention of febrile, acute respiratory disease. J Infect Dis 1992; 166:365-73.
41. Bingen E, Leclercq R, Fitoussi F, et al. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother 2002; 46:1199-203.
42. MacCallum WG. The pathology of the pneumonia in the United States Army Camps during the winter 1917-1918. New York: Rockefeller Institute for Medical Research, 1919.
43. Parker MT. Necropsy studies of the bacterial complications of influenza. J Infect 1979; 1:9-16.
44. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptococcal infections in children with varicella in Southern California. Pediatr Infect Dis J 1996; 15:146-50.
45. Keefer CS, Rantz LA, Rammelkamp CH. Hemolytic streptococcal pneumonia and empyema: a study of 55 cases with special reference to treatment. Ann Intern Med 1941; 14:1533-50.
46. Lampe RM, Kaplan SL. Group A streptococcal empyema complicating Mycoplasma pneumonias infection. South Med J 1982; 75:885-7.
47. Cimolai N, Wensley D, Seear M, Thomas ET. Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin Infect Dis 1995; 21: 1182-5.
48. Bisno AL, Stevens DL. Streptococcus pyogenes (including streptococcal toxic shock syndrome and necrotizing fasciitis). In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:2113.
49. Barnham M, Weightman N, Anderson A, Pagan F, Chapman S. Review of 17 cases of pneumonia caused by Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 1999; 18:506-9.
50. Shet A, Kaplan EL. Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J 2002; 21:420-30.
51. Roggiani M, Stoehr JA, Olmsted SB, et al. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect Immun 2000; 68:5011-7.
52. Stevens DL. The flesh-eating bacterium: what's next? J Infect Dis 1999; 179(Suppl 2):S366-74.
53. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
54. Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β synthesis. J Infect Dis 1993; 168:232-5.
55. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002; 2:156-62.